Troax Group (TROAX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Order intake and sales both declined 4% year-over-year to EUR 69.5 million and EUR 68.3 million, respectively, with organic growth down 5% and a 1% positive FX effect.
Americas and APAC regions showed strong growth, with APAC surging 94% and Americas up 7%, while Europe, especially Northern and Southern regions, experienced double-digit declines.
EBITA margin fell to 14.0% from 15.5% year-over-year, mainly due to higher SG&A costs and lower production volumes in Europe, though gross margin improved to 37.5%.
Working capital discipline and stable net debt/EBITDA at 0.9 supported continued investments and growth initiatives, including the new Tennessee factory and Active Safety segment.
Organizational restructuring effective January 2025 decentralized decision-making and introduced a new regional reporting structure (EMEA, Americas, APAC).
Financial highlights
Order intake: EUR 69.5 million, down 4% year-over-year; sales: EUR 68.3 million, down 4% year-over-year.
EBITA: EUR 9.5 million (14.0% margin), down from EUR 11.0 million (15.5% margin) last year.
Gross profit: EUR 25.6 million, gross margin 37.5% (up from 36.2%).
Adjusted EPS: EUR 0.10, down from EUR 0.12 or 0.13 year-over-year.
Operating cash flow: EUR 3.8 million, following typical seasonal pattern; net debt/EBITDA: 0.9.
Outlook and guidance
Management expects continued geographical disparities, with Asia and North America performing well and Europe remaining weak.
SG&A costs expected to decrease in Q2 due to seasonal factors and cost discipline.
Capacity adjustments planned in Europe to align with weaker demand, with potential positive cost effects in 2025.
Low net debt provides opportunities for acquisitions and further investments.
No material postponed volumes from Q1 into Q2; order intake seen as representative of current activity.
Latest events from Troax Group
- Sales and profit fell on weak demand and restructuring, but APAC growth and acquisitions support recovery.TROAX
Q4 20255 Feb 2026 - Order intake and sales rose, but margin and profit declined amid market headwinds.TROAX
Q2 20241 Feb 2026 - Sales up 12% and EBITA margin 19.7%, with strong cash flow and global strategic investments.TROAX
Q3 202418 Jan 2026 - Q4 2024 order intake up 12%, EBITA margin 17.2%, strong cash flow, and stable dividend.TROAX
Q4 202423 Dec 2025 - Doubling sales to €550m by 2030, targeting 20% EBITA margin through regional growth and M&A.TROAX
CMD 202520 Nov 2025 - Order intake and sales declined, but cost savings and a strong balance sheet support future growth.TROAX
Q2 202518 Nov 2025 - Order intake and sales fell 7% YoY, but APAC growth and new targets support future optimism.TROAX
Q3 202530 Oct 2025